Ballout R, Livinski A, Fu Y, Steiner R, Remaley A
Cochrane Database Syst Rev. 2022; 11:CD013521.
PMID: 36373961
PMC: 9661876.
DOI: 10.1002/14651858.CD013521.pub2.
Shahnawaz S, Nawaz U, Zaugg J, Hussain G, Malik N, Dogar M
Antioxidants (Basel). 2021; 10(11).
PMID: 34829614
PMC: 8614945.
DOI: 10.3390/antiox10111742.
Roland M, Godang K, Aukrust P, Henriksen T, Lekva T
Sci Rep. 2021; 11(1):6213.
PMID: 33737686
PMC: 7973737.
DOI: 10.1038/s41598-021-85777-3.
Jayalekshmi V, Ramachandran S
Mol Cell Biochem. 2020; 476(1):401-416.
PMID: 32964393
DOI: 10.1007/s11010-020-03916-2.
Pecks U, Bornemann V, Klein A, Segger L, Maass N, Alkatout I
Lipids Health Dis. 2019; 18(1):185.
PMID: 31653257
PMC: 6815065.
DOI: 10.1186/s12944-019-1117-1.
Physiology and Pathophysiology of Steroid Biosynthesis, Transport and Metabolism in the Human Placenta.
Chatuphonprasert W, Jarukamjorn K, Ellinger I
Front Pharmacol. 2018; 9:1027.
PMID: 30258364
PMC: 6144938.
DOI: 10.3389/fphar.2018.01027.
Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal size.
Papacleovoulou G, Nikolova V, Oduwole O, Chambers J, Vazquez-Lopez M, Jansen E
FASEB J. 2017; 31(4):1698-1708.
PMID: 28082353
PMC: 5566176.
DOI: 10.1096/fj.201601032R.
Maternal ABCA1 genotype is associated with severity of Smith-Lemli-Opitz syndrome and with viability of patients homozygous for null mutations.
Lanthaler B, Steichen-Gersdorf E, Kollerits B, Zschocke J, Witsch-Baumgartner M
Eur J Hum Genet. 2012; 21(3):286-93.
PMID: 22929031
PMC: 3573202.
DOI: 10.1038/ejhg.2012.169.
Malformation syndromes caused by disorders of cholesterol synthesis.
Porter F, Herman G
J Lipid Res. 2010; 52(1):6-34.
PMID: 20929975
PMC: 2999931.
DOI: 10.1194/jlr.R009548.
Transport of maternal cholesterol to the fetus is affected by maternal plasma cholesterol concentrations in the golden Syrian hamster.
Burke K, Colvin P, Myatt L, Graf G, Schroeder F, Woollett L
J Lipid Res. 2009; 50(6):1146-55.
PMID: 19122238
PMC: 2681396.
DOI: 10.1194/jlr.M800538-JLR200.
Characterization of placental cholesterol transport: ABCA1 is a potential target for in utero therapy of Smith-Lemli-Opitz syndrome.
Lindegaard M, Wassif C, Vaisman B, Amar M, Wasmuth E, Shamburek R
Hum Mol Genet. 2008; 17(23):3806-13.
PMID: 18775956
PMC: 2581429.
DOI: 10.1093/hmg/ddn278.
Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.
Jenkins K, Merkens L, Tubb M, Myatt L, Davidson W, Steiner R
Mol Genet Metab. 2008; 94(2):240-7.
PMID: 18346920
PMC: 3037116.
DOI: 10.1016/j.ymgme.2008.01.015.
Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome.
Witsch-Baumgartner M, Gruber M, Kraft H, Rossi M, Clayton P, Giros M
J Med Genet. 2004; 41(8):577-84.
PMID: 15286151
PMC: 1735869.
DOI: 10.1136/jmg.2004.018085.
Disorders of cholesterol biosynthesis.
Clayton P
Arch Dis Child. 1998; 78(2):185-9.
PMID: 9579167
PMC: 1717457.
DOI: 10.1136/adc.78.2.185.
Lipid status and fatty acid metabolism in phenylketonuria.
Giovannini M, Biasucci G, Agostoni C, Luotti D, Riva E
J Inherit Metab Dis. 1995; 18(3):265-72.
PMID: 7474891
DOI: 10.1007/BF00710414.
Sterol synthesis and low density lipoprotein clearance in vivo in the pregnant rat, placenta, and fetus. Sources for tissue cholesterol during fetal development.
Belknap W, Dietschy J
J Clin Invest. 1988; 82(6):2077-85.
PMID: 3198766
PMC: 442791.
DOI: 10.1172/JCI113829.
3-Hydroxy-3-methylglutaryl coenzyme A reductase in anencephalic and normal human fetal liver.
Carr B, Rainey W, Mason J
J Clin Invest. 1985; 76(5):1946-9.
PMID: 2997298
PMC: 424248.
DOI: 10.1172/JCI112192.
Problems related to diet management of maternal phenylketonuria.
ACOSTA P
J Inherit Metab Dis. 1986; 9 Suppl 2:183-201.
PMID: 2877116
DOI: 10.1007/BF01799703.
